LV13346B - Pharmaceutical tablets containing tibolone and a coating - Google Patents

Pharmaceutical tablets containing tibolone and a coating Download PDF

Info

Publication number
LV13346B
LV13346B LVP-05-72A LV050072A LV13346B LV 13346 B LV13346 B LV 13346B LV 050072 A LV050072 A LV 050072A LV 13346 B LV13346 B LV 13346B
Authority
LV
Latvia
Prior art keywords
coating
sugar
tablets
tibolone
film
Prior art date
Application number
LVP-05-72A
Other languages
English (en)
Latvian (lv)
Inventor
Haan Pieter De
Lare Cornelis Elisabeth Jo Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of LV13346B publication Critical patent/LV13346B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
LVP-05-72A 2002-11-20 2005-06-17 Pharmaceutical tablets containing tibolone and a coating LV13346B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42774002P 2002-11-20 2002-11-20
EP02079920 2002-11-20

Publications (1)

Publication Number Publication Date
LV13346B true LV13346B (en) 2005-12-20

Family

ID=32327854

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-05-72A LV13346B (en) 2002-11-20 2005-06-17 Pharmaceutical tablets containing tibolone and a coating

Country Status (11)

Country Link
US (1) US20060051420A1 (es)
KR (1) KR20050085024A (es)
AR (1) AR042083A1 (es)
CL (1) CL2003002385A1 (es)
CO (1) CO5590891A2 (es)
EC (1) ECSP055811A (es)
HR (1) HRP20050430A2 (es)
IS (1) IS7821A (es)
LV (1) LV13346B (es)
NO (1) NO20052305L (es)
PE (1) PE20040839A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005027879A1 (en) * 2003-09-24 2005-03-31 Novartis Consumer Health S.A. Coated tablets

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3751277A (en) * 1971-03-24 1973-08-07 Dow Chemical Co Tablet coating process and composition
AU671706B2 (en) * 1993-03-05 1996-09-05 Akzo N.V. Use of a Pregnane Derivative
AU680019B2 (en) * 1993-08-30 1997-07-17 Warner-Lambert Company Llc Tablet coating based on a melt-spun mixture of a saccharide and apolymer

Also Published As

Publication number Publication date
CO5590891A2 (es) 2005-12-30
CL2003002385A1 (es) 2005-01-14
IS7821A (is) 2005-04-25
US20060051420A1 (en) 2006-03-09
HRP20050430A2 (en) 2005-06-30
ECSP055811A (es) 2005-08-11
PE20040839A1 (es) 2004-11-17
AR042083A1 (es) 2005-06-08
NO20052305L (no) 2005-06-07
KR20050085024A (ko) 2005-08-29

Similar Documents

Publication Publication Date Title
EP0496437B1 (en) Use of specific core material and layers to obtain pharmaceutical formulations stable to discolouration of omeprazole
US3957523A (en) Coating compositions for solid medicines
CA2724533C (en) Stabilized atypical antipsychotic formulation
JP5052051B2 (ja) 腸溶性顆粒剤及びその製造方法
JP5424877B2 (ja) 小腸における活性成分の放出を制御した経口投与用の医薬品製剤およびその製造方法
JP2002527468A (ja) 脈動用量薬剤経口送達システム
MXPA06003646A (es) Composicion farmaceutica de multi-particulas que comprende acido micofenolico o micofenolato de sodio y combinacion con rapamicina.
AU2010201841A1 (en) Pharmaceutical formulations for the treatment of overactive bladder
KR20020059771A (ko) 정제 코어의 코팅 방법
AU634660B2 (en) Pharmaceutical formulation and method for the control of hypertension and the symptoms of angina over a twenty-four hour period
JP2000212075A (ja) 貯蔵安定な放出様相を有する徐放性トラマド―ル調合物及びその製造方法
JPH0987169A (ja) 消化管下部放出型被覆カプセル製剤
ES2963929T3 (es) Forma farmacéutica oral multipartículas que proporciona liberación prolongada de tapentadol
JP5070618B2 (ja) 腸溶性顆粒剤及びその製造方法
LV13346B (en) Pharmaceutical tablets containing tibolone and a coating
NZ539715A (en) Pharmaceutical tablets containing tibolone and a coating, which reduces the formation of the tibolone-derived isomerisation degradation product OM38
EP4327806A1 (en) Capsule for specific drug delivery and preparation method therefor
EP3290023B1 (en) Rivastigmine-containing sustained-release pharmaceutical composition
ZA200503479B (en) Pharmaceutical tablets containing tibolone and a coating
JPS62240618A (ja) 持続性製剤
US5980952A (en) Pharmaceutical composition for the programmed release of dexfenfluramine
JPS615010A (ja) 水素添加麦角アルカロイド徐放性製剤及びその製法
EP2221049A2 (en) Solid pharmaceutical composition of ded anosine
MXPA97010305A (es) Procedimiento de preparación de la composición de acción prolongada de gránulos conteniendo 4-nitro-2-fenoximetanosulfonanilida
IE62640B1 (en) Novel dosage form